{"id":"https://openalex.org/W2315355673","doi":"https://doi.org/10.2174/2212697x113026660005","title":"Preclinical Models to Study Breast Cancer","display_name":"Preclinical Models to Study Breast Cancer","publication_year":2014,"publication_date":"2014-05-31","ids":{"openalex":"https://openalex.org/W2315355673","doi":"https://doi.org/10.2174/2212697x113026660005","mag":"2315355673"},"language":"en","primary_location":{"id":"doi:10.2174/2212697x113026660005","doi":"https://doi.org/10.2174/2212697x113026660005","is_oa":false,"landing_page_url":"https://doi.org/10.2174/2212697x113026660005","pdf_url":null,"source":{"id":"https://openalex.org/S4210179923","display_name":"Clinical Cancer Drugs","issn_l":"2212-697X","issn":["2212-697X","2212-6988"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Drugs","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025938619","display_name":"Cynthia Rodriguez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cynthia Rodriguez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110639377","display_name":"Paloma Valenzuela","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paloma Valenzuela","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024815516","display_name":"Natzidielly Lerma","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Natzidielly Lerma","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5075999310","display_name":"Giulio Francia","orcid":"https://orcid.org/0000-0002-3752-3070","observed_orcids":["https://orcid.org/0000-0002-3752-3070"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Giulio Francia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.21726408,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"1","issue":"2","first_page":"90","last_page":"99"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.6547999978065491,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.6547999978065491,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.2750999927520752,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11134","display_name":"Breast Lesions and Carcinomas","score":0.011300000362098217,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9259999990463257},{"id":"https://openalex.org/keywords/preclinical-models","display_name":"preclinical models","score":0.8939999938011169},{"id":"https://openalex.org/keywords/breast-cancer-cell-lines","display_name":"breast cancer cell lines","score":0.8899999856948853},{"id":"https://openalex.org/keywords/mda-mb-231-cells","display_name":"MDA-MB-231 cells","score":0.9710000157356262},{"id":"https://openalex.org/keywords/mcf-7-cells","display_name":"MCF-7 cells","score":0.9990000128746033},{"id":"https://openalex.org/keywords/bt474-cells","display_name":"BT474 cells","score":0.9909999966621399},{"id":"https://openalex.org/keywords/t47d-cells","display_name":"T47D cells","score":0.9890000224113464},{"id":"https://openalex.org/keywords/nci-60-cell-lines","display_name":"NCI-60 cell lines","score":0.8619999885559082},{"id":"https://openalex.org/keywords/xenografts","display_name":"xenografts","score":0.824999988079071},{"id":"https://openalex.org/keywords/organotypic-culture","display_name":"organotypic culture","score":0.7749999761581421},{"id":"https://openalex.org/keywords/drug-screening","display_name":"drug screening","score":0.7089999914169312},{"id":"https://openalex.org/keywords/metastasis","display_name":"metastasis","score":0.753000020980835},{"id":"https://openalex.org/keywords/metronomic-chemotherapy","display_name":"metronomic chemotherapy","score":0.8550000190734863},{"id":"https://openalex.org/keywords/her2-targeted-therapy","display_name":"HER2-targeted therapy","score":0.7749999761581421},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":1.0},{"id":"https://openalex.org/keywords/pertuzumab","display_name":"pertuzumab","score":0.9649999737739563},{"id":"https://openalex.org/keywords/molecular-markers","display_name":"molecular markers","score":0.3970000147819519},{"id":"https://openalex.org/keywords/in-vivo-monitoring","display_name":"in vivo monitoring","score":0.4000000059604645}],"concepts":[{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6917851567268372},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5959833860397339},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5880581736564636},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.5437636375427246},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5182487964630127},{"id":"https://openalex.org/C2781188995","wikidata":"https://www.wikidata.org/wiki/Q6934982","display_name":"Multiplex","level":2,"score":0.4853860139846802},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.4707375466823578},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.41103237867355347},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.39103299379348755},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.37496882677078247},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3668779134750366},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.35700690746307373},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.24891448020935059},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.21111521124839783},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20860496163368225},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.16366136074066162}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2174/2212697x113026660005","doi":"https://doi.org/10.2174/2212697x113026660005","is_oa":false,"landing_page_url":"https://doi.org/10.2174/2212697x113026660005","pdf_url":null,"source":{"id":"https://openalex.org/S4210179923","display_name":"Clinical Cancer Drugs","issn_l":"2212-697X","issn":["2212-697X","2212-6988"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Drugs","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320306076","display_name":"National Science Foundation","ror":"https://ror.org/021nxhr62"},{"id":"https://openalex.org/F4320333121","display_name":"University of Texas at El Paso","ror":"https://ror.org/04d5vba33"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7133421939","https://openalex.org/W3133344639","https://openalex.org/W4362595703","https://openalex.org/W6963687785","https://openalex.org/W7097712375","https://openalex.org/W4409050762","https://openalex.org/W2497345858","https://openalex.org/W2605267422","https://openalex.org/W1593681564","https://openalex.org/W2946202501"],"abstract_inverted_index":{"The":[0,156],"nucleation":[1],"of":[2,11,37,52,55,66,69,94,96,115,126,128,138,179,190,213,225,248],"many":[3],"breast":[4,28,70,240],"cancer":[5,29,119,241,274],"research":[6],"projects":[7],"is":[8,32,39,160],"the":[9,53,56,64,92,97,116,136,145,202,211,220,233,236,246],"choice":[10],"an":[12],"appropriate":[13],"model":[14,146,159],"to":[15,22,42,48,87,135,185,231,238],"be":[16,23,143],"used,":[17],"and":[18,34,83,123,130,151,200,235,266],"a":[19,26,35,61,139],"central":[20],"question":[21],"addressed.":[24],"Often,":[25],"human":[27],"cell":[30,76,120,192,271],"line":[31,121],"chosen,":[33],"selection":[36,65],"assays":[38],"then":[40],"employed":[41],"test":[43],"new":[44],"anti-cancer":[45],"agents,":[46],"or":[47,256],"study":[49],"some":[50,191],"aspect":[51],"biology":[54],"disease.":[57,182,226],"Here,":[58],"we":[59],"provide":[60,228],"guide":[62],"for":[63,107,219],"preclinical":[67,158],"models":[68,175,203],"cancer,":[71,270],"focusing":[72],"on":[73,245],"commonly":[74],"chosen":[75],"lines,":[77,193,272],"including":[78,243],"MDA-MB-231,":[79],"MCF-7,":[80],"BT-474,":[81],"T47D,":[82],"ZR75.1.":[84],"Important":[85],"criteria":[86,184],"consider":[88,186],"include,":[89],"among":[90],"others,":[91],"ease":[93],"growth":[95],"cells,":[98],"whether":[99,111,144,201],"they":[100,112],"can":[101,147,154],"form":[102],"organotypic":[103],"cultures,":[104],"their":[105,124],"amenability":[106],"drug":[108,198],"screening":[109],"assays,":[110],"are":[113],"part":[114],"NCI":[117],"60":[118],"panel,":[122],"array":[125],"expression":[127],"oncogenes":[129],"tumor":[131],"suppressor":[132],"genes.":[133],"Critical":[134],"success":[137],"project":[140],"may":[141,195],"also":[142],"grow":[148],"in":[149,166,221,257],"vivo,":[150],"if":[152],"it":[153],"metastasize.":[155],"ideal":[157],"therefore":[161],"one":[162],"that":[163,176,217],"permits":[164],"multiplex":[165],"vitro":[167],"screens":[168],"as":[169,171,208,210,264],"well":[170,209],"complex,":[172],"orthotopic,":[173],"animal":[174],"replicate":[177],"aspects":[178],"late":[180],"stage":[181],"Additional":[183],"include":[187],"proprietary":[188],"restrictions":[189],"which":[194],"later":[196],"hamper":[197],"development,":[199],"comply":[204],"with":[205,259],"institutional":[206],"guidelines,":[207],"possibility":[212],"incorporating":[214],"molecular":[215],"markers":[216],"allow":[218],"vivo":[222],"non-invasive":[223],"monitoring":[224],"We":[227],"practical":[229],"examples":[230],"illustrate":[232],"challenges":[234],"solutions":[237],"developing":[239],"projects,":[242],"studies":[244],"treatment":[247],"metastatic":[249],"disease":[250],"using":[251],"metronomic":[252],"chemotherapy,":[253],"either":[254],"alone":[255],"combination":[258],"anti-Her-2":[260],"targeting":[261],"strategies,":[262],"such":[263],"trastuzumab":[265],"pertuzumab.":[267],"Keywords:":[268],"Breast":[269],"xenografts,":[273],"therapeutics.":[275]},"counts_by_year":[{"year":2020,"cited_by_count":1}],"updated_date":"2026-06-25T06:16:34.145877","created_date":"2016-06-24T00:00:00"}